statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HC Wainwright upgraded shares of Synlogic (NASDAQ:SYBX  Free Report) from a sell rating to a neutral rating in a report published on Wednesday, Marketbeat Ratings reports. HC Wainwright also...

Synlogic (NASDAQ:SYBX) Raised to Neutral at HC Wainwright

Synlogic, Inc. (NASDAQ:SYBX  Free Report)  Equities researchers at HC Wainwright lowered their Q1 2024 EPS estimates for Synlogic in a report issued on Wednesday, March 20th. HC...

Q1 2024 EPS Estimates for Synlogic, Inc. Cut by Analyst (NASDAQ:SYBX)

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Synlogic reports Q4 EPS ($1.71), consensus (97c)

CAMBRIDGE, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today...

Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results

Synlogic, Inc. (NASDAQ: SYBX) came out with a quarterly loss of $1.71 per share versus the Zacks Consensus Estimate of a loss of $1.11. This compares to loss of $3.60 per share a year ago. These...

Synlogic, Inc. (SYBX) Reports Q4 Loss, Tops Revenue Estimates

Harbor Capital Advisors Inc. lifted its position in shares of Synlogic, Inc. (NASDAQ:SYBX  Free Report) by 43.4% during the 4th quarter, according to the company in its most recent Form 13F...

Harbor Capital Advisors Inc. Purchases 9,282 Shares of Synlogic, Inc. (NASDAQ:SYBX)

Synlogic, Inc. (NASDAQ:SYBX  Get Free Report) was the recipient of a significant decrease in short interest in February. As of February 29th, there was short interest totalling 20,700 shares...

Synlogic, Inc. (NASDAQ:SYBX) Sees Significant Decline in Short Interest

Synlogic approves shareholder rights plan, authorizes dividend distribution

Synlogic engaged Ladenburg to assist in strategic review

Engages Ladenburg Thalmann as financial advisor to assist with previously announced strategic review processCAMBRIDGE, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a...

Synlogic Adopts Limited Duration Stockholders Rights Plan

Synlogic, Inc. is a biopharmaceutical company which engages in the discovery and development of synthetic biotic medicines. It focuses on phenylketonuria, enteric hyperoxaluria, immuno-oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs. The company was founded by James J. Collins and Timothy K. Lu on December 20, 2007 and is headquartered in Cambridge, MA.

Volume	17,357.00
52-Wk High	$10.20
52-Wk Low	$1.55

Period	Estimated	Reported	Surprise	Result
Q1'24	-$0.82	--	--	N/A
Q4'23	-$0.93	-$1.71	-83.21%	MISSED
Q3'23	-$2.18	-$2.57	-17.89%	MISSED
Q2'23	-$3.55	-$3.15	11.27%	BEAT
Q1'23	-$3.49	-$3.45	1.08%	BEAT

SYBX Synlogic Inc

About

Feed

News

Sentiment

Earnings

Fundamentals